Webinar | Proton Therapy| May 31, 2016

Webinar: Expanding Oncology Services With Proton Therapy

This webinar is sponsored by IBA

proton therapy, IBA, proteusPlus

This one-hour webinar explains how a community hospital, Willis-Knighton Health Systems, established a proton therapy center in less than 13 months. The Willis-Knighton Proton Therapy Center, adjacent to the hospital's existing cancer center, allows for economies of scale and continuity of care, and contains the world's first compact pencil-beam scanning proton therapy system. Experts who set up the Willis-Knighton Proton Therapy Center explains the clinical benefits of proton therapy and how it can potentially expand oncology services.

This webinar took place Thursday, June 30. 

Access the archived version of this webinar

 

Presenters

Lane Rosen, M.D., medical director of radiation oncology, Willis-Knighton Health System, Shreveport, La., is board certified (American Board Radiology). He has special interests in female malignancies, TomoTherapy, treatment of previously irradiated tumors, high dose rate (HDR) brachytherapy, and intensity modulated proton therapy (IMPT). A fifth-generation Shreveport native, Rosen is a member of the Shreveport Medical Society, Louisiana State Medical Society, the American Medical Association, the Association of Residents in Radiation Oncology (residency), the American Society of Therapeutic Radiology and Oncology, the American College of Radiation Oncology, and the Society of Neuro-Oncology.

 

Greg Sonnenfeld, director, Willis-Knighton Cancer Center – Willis-Knighton Health System, has been in healthcare for more than 15 years. He was instrumental in the development, construction and operation of the Willis-Knighton Proton Therapy Center and has led the oncology team to tremendous growth in the past seven years. Sonnenfeld has spoken on proton therapy at numerous symposiums and is an expert on proton therapy in the community hospital setting.

 

 

Mary Elizabeth (Beth) Klein, president, IBA Proton Therapy North America, is a tenured healthcare executive responsible for leading IBA’s Proton Therapy business in North America. Prior to joining IBA in 2009, she spent 27 years at GE Healthcare in sales, marketing and product development in CT, MR and ultrasound. She led GE’s unprecedented growth in nuclear imaging and PET as the global general manager for that business, and completed her tenure at GE Healthcare as the president and CEO of the Americas. She was also the commercial executive at TomoTherapy responsible for its orders ramp in 2005-2007 and played a key role in its public offering. Beth is passionately committed to growing proton therapy as a important tool in delivering more effective cancer treatments for patients.

 

 

About IBA

IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer to the medical communities and their patients. The company is the worldwide technology leader in the field of proton therapy, the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single-room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,200 people worldwide, IBA is listed on the Pan-European stock exchange EURONEXT. (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB) More information can be found at: www.iba-worldwide.com. 

About Willis-Knighton Medical Center

Founded in 1924 as Tri-State Sanitarium in Shreveport, La., Willis-Knighton Medical Center was renamed in 1950 to honor the two physicians who purchased the hospital and transitioned it to a not-for-profit healthcare organization. Today, it encompasses multiple facilities, including four hospitals, a full range of support services, and a retirement community. It spans the entire continuum of care for residents in northwest Louisiana and the Ark-La-Tex area. Willis-Knighton was the first private hospital in the state to team with a public, academic medical center, Louisiana Health Sciences Center in Shreveport, on collaborative ventures. Great strides in cancer care have been made at the Willis-Knighton Cancer Center, one of the first in the world to introduce TomoTherapy image-guided radiation therapy. As a locally owned, locally operated healthcare organization, Willis-Knighton supports continuing efforts to enhance Shreveport’s position as a hub of healthcare excellence.

 

Access the archived version of this webinar

Related Content

News | PACS | June 23, 2017
Medidata and Median Technologies announced a new collaboration to streamline the growth and use of medical imaging in...
ASTRO Issues Guideline for Stereotactic Radiation Use in Early-Stage Lung Cancer
Feature | Lung Cancer | June 23, 2017
The American Society for Radiation Oncology (ASTRO) recently issued a new clinical guideline for the use of...
University of Wisconsin-Madison Partners With RaySearch on RayCare OIS
News | Oncology Information Management Systems (OIMS) | June 21, 2017
The Department of Human Oncology at the University of Wisconsin-Madison has entered into an agreement with RaySearch to...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
Henry Ford Cancer Institute First in World to Install Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 19, 2017
The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer patients advanced...
News | Radiation Oncology | June 12, 2017
The alliance will study the feasibility of using CRnR’s converging x-ray lens technology as an effective radiotherapy...
stereotactic body radiation therapy (SBRT)
News | Stereotactic Body Radiation Therapy (SBRT) | June 12, 2017
The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of stereotactic body...
Sponsored Content | Case Study | Radiation Therapy | June 08, 2017
Stereotactic body radiation therapy (SBRT) employs significantly higher per fraction radiation doses than conventional...
Feature | Radiation Therapy | June 07, 2017 | By Melinda Taschetta-Millane
According to the National Institutes of Health (NIH), precision-based medicine is an emerging approach for disease tr
Gamma Knife
News | Radiation Oncology | June 05, 2017
Up to 45 percent of all cancer patients develop brain metastases, tumors that spread to the brain from cancers located...
Overlay Init